Cargando…

Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

Detalles Bibliográficos
Autores principales:	Dave, Bhuvanesh, Landis, Melissa D., Dobrolecki, Lacey E., Wu, Meng-Fen, Zhang, Xiaomei, Westbrook, Thomas F., Hilsenbeck, Susan G., Liu, Dan, Lewis, Michael T., Tweardy, David J., Chang, Jenny C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595620/ http://dx.doi.org/10.1371/annotation/753d15c8-2321-4dc5-9b84-c47bd1bd1639

Ejemplares similares

Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

DRUG-REPOSITIONING SCREENING IDENTIFIED PIPERLONGUMINE AS A DIRECT STAT3 INHIBITOR WITH POTENT ACTIVITY AGAINST BREAST CANCER
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
por: Souto, Eric P., et al.
Publicado: (2022)

Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
por: Souto, Eric P., et al.
Publicado: (2022)

Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3
por: Alten, Jeffrey A., et al.
Publicado: (2008)

Correction: Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3
por: Alten, Jeffrey A., et al.
Publicado: (2008)

Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
por: Tanei, Tomonori, et al.
Publicado: (2016)

Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis
por: Giuliano, Mario, et al.
Publicado: (2015)

Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease
por: Robinson, Prema, et al.
Publicado: (2022)

Patient-derived breast tumor xenografts facilitating personalized cancer therapy
por: Landis, Melissa D, et al.
Publicado: (2013)

Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
por: Xu, Xuejun, et al.
Publicado: (2009)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016)

Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis
por: Robinson, Prema, et al.
Publicado: (2023)

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2019)

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
por: Shi, Aiping, et al.
Publicado: (2015)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
por: Rosato, Roberto R., et al.
Publicado: (2018)

Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
por: Kasembeli, Moses M., et al.
Publicado: (2018)

Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis
por: Ramirez, Arturo B., et al.
Publicado: (2019)

Design and In Vitro Evaluation of Layer by Layer siRNA Nanovectors Targeting Breast Tumor Initiating Cells
por: Jaganathan, Hamsa, et al.
Publicado: (2014)

HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
por: Liu, Yi, et al.
Publicado: (2017)

Synthetic dimensions in ultracold polar molecules
por: Sundar, Bhuvanesh, et al.
Publicado: (2018)

Deconvolution of cancer cell states by the XDec-SM method
por: Murillo, Oscar D., et al.
Publicado: (2023)

Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin
por: Kasembeli, Moses, et al.
Publicado: (2014)

Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers
por: Kasembeli, Moses M., et al.
Publicado: (2023)

C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
por: Balamurugan, Kuppusamy, et al.
Publicado: (2018)

Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation
por: Welte, Thomas, et al.
Publicado: (2016)

Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
por: Zhang, Xulong, et al.
Publicado: (2007)

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer
por: Thangavel, Hariprasad, et al.
Publicado: (2019)

Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
por: Cumaraswamy, Abbarna A., et al.
Publicado: (2014)

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
por: Tonon, Federica, et al.
Publicado: (2021)

CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence
por: Garg, N, et al.
Publicado: (2017)

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
por: Phan, Alexandria T., et al.
Publicado: (2016)

IL-6-Mediated Activation of Stat3α Prevents Trauma/Hemorrhagic Shock-Induced Liver Inflammation
por: Moran, Ana, et al.
Publicado: (2011)

Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts
por: Chen, Di, et al.
Publicado: (2007)

Oxymatrine Attenuates Tumor Growth and Deactivates STAT5 Signaling in a Lung Cancer Xenograft Model
por: Jung, Young Yun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d3gchf153v5oljadfjaa66mg8k